Screening for cytomegalovirus (CMV) infection in allogeneic bone marrow transplantation using a quantitative whole blood polymerase chain reaction (PCR) method: analysis of potential risk factors for CMV infection-Reference-Cited by-同舟云学术

Screening for cytomegalovirus (CMV) infection in allogeneic bone marrow transplantation using a quantitative whole blood polymerase chain reaction (PCR) method: analysis of potential risk factors for CMV infection

Published:2001-02 Issue:3 Volume:27 Page:301-306
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Qamruddin AO,Oppenheim BA,Guiver M,Mutton KJ,Chopra R

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/1702778.pdf

Reference24 articles.

1. Nguyen Q, Champlin R, Giralt S et al. Late cytomegalovirus pneumonia in adult allogeneic blood and marrow transplant recipients Clin Infect Dis 1999 28: 618–623

2. Noble S, Faulds D . Ganciclovir. An update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients Drugs 1998 56: 115–146

3. Stocchi R, Ward KN, Fanin R et al. Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation Haematologica 1999 84: 71–79

4. Prentice HG, Kho P . Clinical strategies for the management of cytomegalovirus infection and disease in allogeneic bone marrow transplant Bone Marrow Transplant 1997 19: 135–142

5. Milpied N . Prophylaxis of cytomegalovirus infection in bone marrow transplant patients Int J Antimicrobial Agents 1996 7: 277–281

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of CMV DNA Antigenemia Status in Patients With Allogeneic Bone Marrow Transplant;Journal of Basic and Clinical Health Sciences;2024-05-31

2. Incidence, Risk Factors, and Outcome of Cytomegalovirus Viremia and Gastroenteritis in Patients with Gastrointestinal Graft-versus-Host Disease;Biology of Blood and Marrow Transplantation;2015-01

3. Evolution of peripheral blood T lymphocyte subsets after allogenic or autologous hematopoietic stem cell transplantation;Immunobiology;2014-08

4. Cytomegalovirus Infection in Pediatric Allogenic Hematopoietic Stem Cell Transplantation. A Single Center Experience;Pediatric Hematology and Oncology;2013-12-05

5. Oral valganciclovir versus ganciclovir as delayed pre-emptive therapy for patients after allogeneic hematopoietic stem cell transplant: a pilot trial (04-0274) and review of the literature;Transplant Infectious Disease;2011-10-28